Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Twitter Maria Mar Hernandez Guillamon Twitter Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Projects Beneficio de la Simvastatina en el tratamiento trombólico combinado del ictus en modelos de isquemia cerebral en rata IP: Maria Mar Hernandez Guillamon Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 126687 Reference: PI080481 Duration: 01/01/2009 - 31/12/2011 Grup de Recerca en Malalties Neurovasculars IP: Joan Montaner Villalonga Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 46800 Reference: 2009 SGR 432 Duration: 01/01/2010 - 30/04/2014 Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial IP: Joan Montaner Villalonga Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez Funding agency: Instituto de Salud Carlos III Funding: 175450 Reference: EC07/90195 Duration: 01/11/2007 - 30/06/2012 Estudio sobre las causas que originan diferencias de género en la enfermedad neurovascular ¿Es el Ictus una patología machista? IP: Joan Montaner Villalonga Collaborators: Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez Funding agency: Instituto de Salud Carlos III Funding: 41910 Reference: MD07/00209 Duration: 01/01/2008 - 31/05/2009 Pagination First page « Previous page ‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 Next page › Last page »
